Expression of P-gP in patients with resistant tuberculosis

I. Neves, M. Costa, S. Carvalho, L. De Castro (Rio de Janeiro, Brazil)

Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Session: Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Session type: Thematic Poster Session
Number: 2643
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Neves, M. Costa, S. Carvalho, L. De Castro (Rio de Janeiro, Brazil). Expression of P-gP in patients with resistant tuberculosis. Eur Respir J 2012; 40: Suppl. 56, 2643

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Multidrug resistant tuberculosis in non HIV patients
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


Lipid profile in patients with multidrug resistant pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 361s
Year: 2002

Treatment of multidrug resistant pulmonary tuberculosis (MDR-TB) with different pattern of resistance
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004

Outcomes of patients with multidrug resistant tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

Evaluation of characteristics and treatment results of patients treated as multidrug resistant tuberculosis
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012

Susceptibility of Mycobacterium tuberculosis strains to fluoquinolones, obtained from chronic patients with multidrug resistant pulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001

Follow-up and treatment of patients who were diagnosed multidrug resistant tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 11s
Year: 2006

Treatment outcome of multi-drug resistant tuberculosis
Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis
Year: 2004


Treatment results of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005

Rapid molecular detection of rifampicin and isoniazid resistance and identification of mutations in resistant genes of multi-drug resistant tuberculosis (MDR-TB) patients
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011


Outcome of multidrug resistant pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010


Treatment of resistant tuberculosis in patients having isolates resistant to multiple antituberculosis drugs
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010

Surgical treatment of patients with disseminated destructive multidrug resistant lung tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 489s
Year: 2005

Treatment possibilities of multi-drug resistant (MDR) tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 525s
Year: 2003

Treatment‘s side effects in MDR tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 454s
Year: 2005

The surgery of multidrug resistant tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 556s
Year: 2003

Characteristics of the cases with primary multidrug resistance pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

Comparative analysis between multidrug resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis (XDR-TB) in HIV(+) patients
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009


Surgical treatment of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009


Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011